RALGA (Diacnéal®) Decreases Melanin Content in a Human Skin Model
RALGA (Diacnéal®) Decreases Melanin Content in a Human Skin Model
复制标题
RALGA (Diacnéal®) 降低人体皮肤模型中的黑色素含量
DOI:
10.1159/000081503
复制
发表时间:
2005
期刊:
影响因子:
3.4
通讯作者:
F. Verrière
中科院分区:
文献类型:
--
作者:
S. Boisnic;M. Branchet;T. Nocera;F. Verrière
Background: Retinaldehyde and glycolic acid RALGA (Diacnéal®) are both effective in the topical treatment of acne. A decrease in the postinflammatory pigmentation has been observed after application of Diacnéal during 3 months. Aim: To verify the effect of this association on pigmentation using an original model of surviving human skin. Methods: Human skin explants were maintained alive in organ culture for 14 days. Diacnéal® was applied every day. Pigmentation of skin, depending on the transfer of melanosomes from melanocytes to keratinocytes, was visualized histologically by Fontana-Masson staining. The number of melanocytes was determined after the DOPA reaction. Results: A decrease in melanin content was shown after application of Diacnéal. The number of melanocytes was not modified. Conclusion: These results suggest that RALGA (Diacnéal®) may be of interest to prevent the postinflammatory pigmentation of acne.